Category Archives: BioUtah News
Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica and Valence. “Recursion has pioneered the massive, parallel generation of […]
Vistim Labs Closes First Round of Funding
Vistim Labs Closes First Round of Funding
Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial
Respective leaders in healthcare innovation and RNA diagnostics team up to identify patients who will benefit from immunotherapy
BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List
FRANKLIN LAKES, N.J., May 3, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a “Noteworthy Company” in DiversityInc’s annual ranking of the top U.S. companies for diversity. Since 2001, the DiversityInc Top 50 survey has been the external validator for […]
Ultradent Adds 168,000 Sq. Ft. Facility to Campus
Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials and equipment, is unveiling a new 168,000 sq. ft. facility on its South Jordan campus. The building’s grand opening will feature a 10am MST ribbon cutting on May 3, 2023. Ultradent’s leadership, along with South Jordan Mayor Dawn Ramsey, as well as […]
Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting
NEWS PROVIDED BY BlueWind Medical OASIS study achieves primary and secondary endpoints, safely mitigating the debilitating effects of urgency urinary incontinence Study results show that 78% of those implanted and 82% of patients completing the study achieved at least a 50% reduction in urge incontinence episodes at 12 months At 12 months, 50% of the […]
Bovine-specific ELISAs Now Available from Quansys Biosciences
LOGAN, Utah—A new ELISA kit has been developed that can measure bovine and African Water Buffalo cytokines in plasma, serum, cell culture supernatants. The kit is a sensitive and accurate way to measure the levels of these important proteins, which play a role in a variety of diseases and conditions. Cytokines are small proteins that are […]
NexEos Bio Names Dawn Rubel as President, Research and Development
NexEos Bio today announced that Dawn Rubel has joined the Company as President, Research and Development.
NUSANO TO PRESENT PRODUCTION CAPABILITIES TO EUROPEAN RADIOPHARMACEUTICALS WORKING GROUP
PROPRIETARY ION SOURCE AND BEAM TECHNOLOGY CAPABLE OF PRODUCING APPROXIMATELY 10 TIMES THE CURRENT GLOBAL SUPPLY OF ASTATINE-211
BD Recognized by Forbes as a Best Employer for Diversity in 2023 List
Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J., April 25, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been recognized by Forbes as one of the leading employers in the U.S.for diversity. BD was named to […]
Oxford Nanopore and bioMérieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics
Oxford Nanopore Technologies and bioMérieux SA, a world leader in the field of in vitro diagnostics, today announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market. The companies are jointly exploring selected opportunities to advance patient care by providing […]
ATL Technology Acquires Gyrus Medical LTD. Manufacturing Operations
ATL Technology (ATL), a fast-growing provider of outsourced design, development and manufacturing services to the medical device market, today announced it has acquired manufacturing operations of Gyrus Medical Limited (Gyrus/GML) from Olympus Winter & Ibe GmbH (Olympus Surgical Technologies Europe). Gyrus, located in Cardiff, Wales, United Kingdom, is also a device outsourcer and will increase […]
